多替阿巴拉米片吃完可以喝酒吗

It is a three-in-one compound drug whose main ingredients are dolutegravir 50mg + abacavir 0.6g + lamivudine 0.3g. For the treatment of adults and adolescents over 12 years old (weighing at least 40kg) infected with human immunodeficiency virus (HIV).

The therapeutic advantages of Dolutegra Abalami Tablets are as follows: 1. Excellent efficacy and significant viral suppression effect; 2. The three drugs are equivalent in equivalence; both newly-treated and previously treated patients have a high resistance barrier, which is not likely to lead to drug resistance; 3. It is easy to take and only needs to be taken once a day, without considering food effects; 4. The drug has low side effects and good tolerability, and the discontinuation rate due to drug side effects is low; 5. There are few interactions between metabolic pathways and other drugs.

During drug treatment, it is best for patients to avoid drinking, smoking and other bad lifestyle habits and maintain a happy mood. It is important to note that although viral suppression with antiretroviral therapy has been shown to significantly reduce the risk of sexual transmission, residual risks cannot be ruled out. Precautions should be taken to prevent transmission in accordance with national guidance.

HLA-B*5701 status must be confirmed before starting treatment with Dolutegra. Because patients with positive HLA-B*5701 allele test results are at higher risk of developing abacavir hypersensitivity reactions. Rarely, it can be fatal if not handled properly. Do not restart dolutegravir therapy if you have discontinued the drug due to a hypersensitivity reaction, as this may result in a more severe reaction than the first time.

The use must be started under the guidance of a professional doctor, and the doctor's instructions must be followed during the treatment period, and do not use the medicine blindly.

Recommended related hot articles: /newsDetail/85389.html